Abiopharma

🔍 Freeman Chris (Executive)

Company: Guardant Health, Inc. (GH)

Report Date: 2025-12-05

Detailed Transactions and Holdings:

• Sold 478 shares of Common Stock at $101.4277 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 56,961.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 744 shares of Common Stock at $102.306 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 56,217.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 372 shares of Common Stock at $103.4815 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 55,845.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 244 shares of Common Stock at $104.0985 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 55,601.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 228 shares of Common Stock at $106.6322 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 55,373.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 4,084 shares of Common Stock at $101.4027 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 51,289.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 11,969 shares of Common Stock at $102.0946 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 39,320.00 | transaction_form_type: 4 | Footnotes: F7
• Sold 3,414 shares of Common Stock at $103.2528 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,906.00 | transaction_form_type: 4 | Footnotes: F8
• Sold 6,555 shares of Common Stock at $103.9717 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 29,351.00 | transaction_form_type: 4 | Footnotes: F9
• Sold 400 shares of Common Stock at $105.9863 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 28,951.00 | transaction_form_type: 4 | Footnotes: F10
• Sold 2,964 shares of Common Stock at $106.7081 per share (Direct)
  Date: 2025-12-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 25,987.00 | transaction_form_type: 4 | Footnotes: F11

Footnotes:

• F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.770 to $101.750. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F2: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.810 to $102.700. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F3: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.005 to $103.860. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F4: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.010 to $104.200. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F5: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.450 to $106.735. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F6: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.710 to $101.695. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F7: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.720 to $102.700. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F8: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $102.720 to $103.710. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F9: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.725 to $104.510. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F10: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.415 to $106.390. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F11: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.500 to $106.990. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.